Live feed10:17:00·138dPRReleasevia Quantisnow+2Platform Technologies Drive $211B Surge in Precision Cancer TreatmentByQuantisnow·Wall Street's wire, on your screen.ERAS· Erasca Inc.FHTX· Foghorn Therapeutics Inc.GTBP· GT Biopharma Inc.OABI· OmniAb Inc.RXRX· Recursion Pharmaceuticals Inc.Health Care
